Pfizer/BioNTech COVID-19 vaccine shelf-life extended to 31 days

21 May 2021

New storage conditions for the COVID-19 vaccine from Pfizer (NYSE: PFE) and Germany’s BioNTech (Nasdaq: BNTX) have today been approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).

The new storage conditions extend the length of time the thawed vaccine can be stored at normal fridge temperatures from five days to 31 days,

The Pfizer/BioNTech vaccine, now dubbed Comirnaty in Europe, which was the first COVID-19 vaccine to be approved by the UK regulator in December last year, must be stored at ultra-low temperatures until use. The changes, that extend the shelf-life once thawed, are therefore expected to make storage easier and possible for a wider range of health facilities.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK